This tech investor says the AI nuke trade is a loser. Here’s why.
Josh Wolfe, the co-founder of New York VC firm Lux Capital, says the AI/nuke trade is not going to work out like some ...
Jobless claims show no rise in layoffs in 2024. Don’t expect the trend to end soon.
Businesses laid off workers at one of the lowest rates in decades in 2024 despite lingering inflation and the highest ...
Student-loan borrowers will need to brace for change in 2025. Here are 5 of the biggest shifts.
Experts warn that more borrowers could face garnishment of their Social Security checks, tax refunds and wages as ...
Most bullish Apple analyst gets a little more bullish on AI-enhanced iPhones
Wedbush technology sector analyst Daniel Ives already had the highest price target for the iPhone maker among Wall Street ...
Oil prices climb on Chinese stimulus hopes
Crude oil prices climbed on Thursday as hopes for more Chinese government stimulus helped boost demand for the commodity.
Assembly Biosciences Shares Rise on Results from Hepatitis B Drug Trial
Shares of Assembly Biosciences advanced after the company reported encouraging results from a clinical trial of its treatment for the hepatitis B virus. The stock was up 5.2% at $15.49 in premarket ...
Dow futures lower, Treasury yields higher, after jobless claims
Stock index futures ticked lower in thin post-holiday trade on Thursday following the latest weekly report on jobless claims. Data showed the number of Americans applying for first-time benefits ...
MarketWatch15m
Analyst hikes Apple price target after stock hits record high
Wedbush technology sector analyst Daniel Ives already had the highest price target for the iPhone maker among Wall Street analysts, but on Thursday he boosted it further on an expected surge in ...